SCHEMBL8668121

SCHEMBL8668121

O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCBr

nearest known ligand 0.67

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.67
HDAC2 Q92769 7/20 0.67
RAB9A P51151 1/20 0.61
ADRA1D P25100 2/20 0.54
ADRA1A P35348 2/20 0.54
ADRA1B P35368 2/20 0.54
CA12 O43570 9/20 0.48
CA9 Q16790 8/20 0.48
CA2 P00918 2/20 0.48
CA1 P00915 1/20 0.48
LPAR2 Q9HBW0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8671286 0.90 HDAC1 (0.55) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL8668118 0.86 HDAC1 (0.57) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL30873067 0.80 RAB9A (0.68) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL2010585 0.80 RAB9A (0.68) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL7291555 0.80 RAB9A (0.72) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL8667679 0.79 DRD2 (0.48) HDAC1HDAC2CA12CA9CA2
SCHEMBL8671281 0.79 HDAC1 (0.49) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL9400925 0.77 HTR1A (0.70) HDAC1HDAC2RAB9AADRA1DADRA1A
SCHEMBL7299633 0.76 RAB9A (1.00) HDAC1HDAC2RAB9ACA12CA9
SCHEMBL8670390 0.76 HDAC1 (0.53) HDAC1HDAC2RAB9AADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760054-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1998-06-02 US disclosed
EP-0755392-A4 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1997-05-02 EP disclosed
EP-0755392-A1 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1997-01-29 EP disclosed
WO-1995028397-A1 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1995-10-26 WO disclosed